RZLT

Conviction 83HealthcareScan · Mon, Aug 10, 2026

RZLT$4.68-0.32%

ResistanceSupportVol 14

Vol MA14 1.37M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Rezolute, Inc.PHARMACEUTICAL PREPARATIONSwww.rezolutebio.com ↗

Price4.68

Change-0.32%

Gap+1.28%

Rel volume2.48×

Avg volume1.33M

Avg $ vol6.43M

SMA 204.81

SMA 504.67

SMA 2004.59

Price vs 50+0.08%

Price vs 200+1.79%

MA stackbullish

50/200 crossgolden · 1d

Supertrendup · 4.12

RSI (14)48

MACD hist-0.05

MACD cross—

Stoch %K / %D19 / 23

ADX (14)14

+DI / −DI16 / 19

RSI divergence—

MACD divergence—

ATR %+6.99%

ADR %6.95%

52w high10.94

52w low1.40

From 52w high-57.27%

Above 52w low+233.93%

New 52w highNo

SqueezeOn · 10d

Bollinger width17.81%

%B0.34

Donchian pos42.63%

Donchian high5.40

Donchian low4.14

AVWAP (52w high)3.09

vs AVWAP high+51.35%

AVWAP (52w low)2.68

vs AVWAP low+74.18%

OBV trendFlat

Chaikin MF (20)-0.03

Today vs 20d2.48×

Avg vol (14d)1.37M

Avg vol (20d)1.33M

Avg $ vol (20d)6.43M

Market cap450.17M

RS 3m (vs SPY)+46.08%

RS 6m (vs SPY)+46.50%

RS line new highNo

Trend template4/8

Technical rank54.5

1 week-4.79%

1 month-1.58%

3 months+45.64%

6 months+49.84%

1 year-16.07%

YTD+115.94%

P/E-6.05

P/B3.85

P/S—

P/FCF-6.50

EPS-0.9800

Div yield—

ROE-63.69%

ROA-59.31%

Debt/Eq0.04

Current15.84

EV/EBITDA-5.56

Gross margin—

Net margin—

Rev growth—

EPS growth-8.70%

Price target8.43

Target upside80.32%

Analyst ratingBuy

Institutional95.75%

Ent. value443.95M

Revenue—

Net income-16.17M

Gross profit—

Free cash flow-69.23M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out—

Employees71

ListedFri, Dec 23, 2011

Free float81.78M

Float %85.5%

Short interest16.31M

Days to cover8.8d

Short volume20.1%

Squeeze score80 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.16 vs −$0.13

Last surprise-23.1% miss

Setup gradeA

Conviction83 / 100

Pattern quality—

Tech rank54.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.41

Support4.33

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in RZLT

All disclosures →

No recent disclosed trades by Congress in RZLT. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in RZLT · 3 sells

Insider	Side	Shares	Value	Traded	Filed
Elam Nevan C CEO · Common Shares · 2026-07-02	Tax	8K	$40K	2026-07-02	2026-07-07
Evans Daron CFO · Common Shares · 2026-07-02	Tax	3.06K	$15K	2026-07-02	2026-07-07
ROBERTS BRIAN KENNETH Chief Medical Officer · Common Shares · 2026-07-02	Tax	3.06K	$15K	2026-07-02	2026-07-07

SEC filings

EDGAR filings in RZLT · 1 recent

EDGAR →

8-K8-KMaterial eventTue, Jun 2, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.